MolNFT v1 · #72516 · protein
PDK1 in complex with inhibitor MP7
3NAX · 3-phosphoinositide-dependent protein kinase 1: “PDK1 in complex with inhibitor MP7”. X-ray diffraction, 1 ligand (MP7), 3 pockets (best druggability 0.77). MolNFT v1 #72516 on GenesisL1: 3D structure, binding sites and pockets in…
- PDB
- 3NAX
- Type
- protein
- Length
- 278 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- 3-phosphoinositide-dependent protein kinase 1
- EC
- 2.7.11.1
- UniProt
- O15530
- Ligands
- MP7
- Pockets
- 3 · best druggability 0.77
Structure
x-ray diffraction · 1 distinct chain · 39% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | 3-phosphoinositide-dependent protein kinase 1 (EC 2.7.11.1) | protein | 278 | 39% helix, 19% strand | O15530 |
Ligands and binding sites
- MP7 · 1-(3,4-difluorobenzyl)-2-oxo-N-{(1R)-2-[(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)oxy]-1-phenylethyl}-1,2-dihydropyridine-3-carboxamide · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 259 | 0.77 | 0.90 | 40 | MP7 |
| 2 | 75 | 0.39 | 0.78 | 24 | empty |
| 3 | 63 | 0.28 | 0.73 | 16 | empty |
Compared structures
- 3NAX · PDK1 in complex with inhibitor MP7 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O15530
- Elsewhere: RCSB PDB 3NAX · PDBe 3NAX · UniProt O15530
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.